Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$224.73 - $338.64 $179,784 - $270,912
-800 Closed
0 $0
Q3 2021

Nov 01, 2021

BUY
$310.19 - $376.2 $167,502 - $203,148
540 Added 207.69%
800 $260,000
Q3 2021

Nov 01, 2021

BUY
$310.19 - $376.2 $80,649 - $97,812
260 New
260 $260,000
Q1 2019

May 08, 2019

SELL
$276.39 - $362.25 $186,839 - $244,881
-676 Closed
0 $0
Q4 2018

Feb 11, 2019

BUY
$281.08 - $444.25 $146,442 - $231,454
521 Added 336.13%
676 $219,000
Q3 2018

Nov 09, 2018

SELL
$354.53 - $449.75 $394,237 - $500,122
-1,112 Reduced 87.77%
155 $69,000
Q2 2018

Aug 07, 2018

BUY
$278.07 - $446.21 $352,314 - $565,348
1,267 New
1,267 $518,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Girard Partners Ltd. Portfolio

Follow Girard Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.